Symbol="VYGR"
AssetType="Common Stock"
Name="Voyager Therapeutics Inc"
Description="Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1640266"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="75 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="406622000"
EBITDA="91673000"
PERatio="4.245"
PEGRatio="0"
BookValue="4.548"
DividendPerShare="0"
DividendYield="0"
EPS="2.2"
RevenuePerShareTTM="4.834"
ProfitMargin="0.492"
OperatingMarginTTM="0.448"
ReturnOnAssetsTTM="0.217"
ReturnOnEquityTTM="0.74"
RevenueTTM="194869000"
GrossProfitTTM="-19857000"
DilutedEPSTTM="2.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="5.82"
AnalystTargetPrice="13.67"
TrailingPE="4.245"
ForwardPE="-"
PriceToSalesRatioTTM="3.271"
PriceToBookRatio="2.825"
EVToRevenue="1.667"
EVToEBITDA="-8.56"
Beta="1.06"
num_52WeekHigh="14.34"
num_52WeekLow="4.77"
num_50DayMovingAverage="10.69"
num_200DayMovingAverage="8.36"
SharesOutstanding="43535600"
DividendDate="None"
ExDividendDate="None"
symbol="VYGR"
open="9.08"
high="9.49"
low="9.03"
price="9.34"
volume="290739.00"
latest_trading_day="2023-08-11"
previous_close="9.13"
change="0.21"
change_percent="2.3001%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="28"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="72"
Volume_recent_avg="521858"
Change_recent_avg="0.02"
Delta_recent_avg="0.59"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="72"
Aroon_momentum_negative="28"
image_negative_thumbnail_id_1="1103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_negative_thumbnail_id_2="108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_neutral_thumbnail_id_1="597"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="656"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
